At a glance
ClinicalIndex Comparison RecordN/ACompleted· 194 enrolled
Drug / intervention
530G Insulin pumpdevice
Likely dose
530G Insulin pumpfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
In Brief
A clinical study evaluating 530G Insulin pump for Type 1 Diabetes. Completed, enrolled 194 participants across 16 sites.
Detailed Summary
The study objective is to demonstrate that home use of Threshold Suspend (TS) is not associated with glycemic deterioration in pediatric patients with type 1 diabetes, as measured by change in A1C.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 2014
Enrollment StartJun 2014
Primary CompletionJun 2017
TodayJul 2026
First PostedApr 23, 2014
Enrollment StartJun 1, 2014
Primary CompletionJun 16, 2017
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 12.2 years ago
Interventions
530G Insulin pumpdevice
Subjects will use 530G insulin pump with Threshold Suspend (TS) feature for one year.